Free Trial
NASDAQ:XRAY

DENTSPLY SIRONA (XRAY) Stock Price, News & Analysis

DENTSPLY SIRONA logo
$11.00 +0.04 (+0.36%)
Closing price 04:00 PM Eastern
Extended Trading
$11.04 +0.04 (+0.40%)
As of 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About DENTSPLY SIRONA Stock (NASDAQ:XRAY)

Advanced

Key Stats

Today's Range
$10.75
$11.18
50-Day Range
$10.95
$14.68
52-Week Range
$9.85
$17.18
Volume
6.64 million shs
Average Volume
4.07 million shs
Market Capitalization
$2.20 billion
P/E Ratio
N/A
Dividend Yield
5.82%
Price Target
$13.82
Consensus Rating
Hold

Company Overview

DENTSPLY SIRONA Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

XRAY MarketRank™: 

DENTSPLY SIRONA scored higher than 95% of companies evaluated by MarketBeat, and ranked 33rd out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    DENTSPLY SIRONA has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 3 buy ratings, 8 hold ratings, and 3 sell ratings.

  • Upside Potential

    DENTSPLY SIRONA has a consensus price target of $13.82, representing about 25.6% upside from its current price of $11.00.

  • Amount of Analyst Coverage

    DENTSPLY SIRONA has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about DENTSPLY SIRONA's stock forecast and price target.
  • Earnings Growth

    Earnings for DENTSPLY SIRONA are expected to grow by 9.15% in the coming year, from $1.42 to $1.55 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of DENTSPLY SIRONA is -3.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of DENTSPLY SIRONA is -3.49, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    DENTSPLY SIRONA has a PEG Ratio of 1.30. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    DENTSPLY SIRONA has a P/B Ratio of 1.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for XRAY.
  • Dividend Leadership

    DENTSPLY SIRONA is a leading dividend payer. It pays a dividend yield of 5.84%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    DENTSPLY SIRONA has been increasing its dividend for 13 years.

  • Dividend Sustainability

    Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 41.29% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.

  • Read more about DENTSPLY SIRONA's dividend.
  • News Sentiment

    DENTSPLY SIRONA has a news sentiment score of -0.26. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.45 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 21 news articles for DENTSPLY SIRONA this week, compared to 5 articles on an average week.
  • Search Interest

    Only 15 people have searched for XRAY on MarketBeat in the last 30 days. This is a decrease of -6% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added DENTSPLY SIRONA to their MarketBeat watchlist in the last 30 days.
  • Cluster Insider Buying

    2 insiders have purchased shares of DENTSPLY SIRONA in the last three months. Multiple insiders buying is a strong bullish signal.

  • Net Insider Buying

    Over the last three months, insiders have purchased a net $956,437.00 in company stock, which represents 0.0434% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, DENTSPLY SIRONA insiders have bought more of their company's stock than they have sold. Specifically, they have bought $956,437.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    0.50% of the stock of DENTSPLY SIRONA is held by insiders.

  • Percentage Held by Institutions

    95.70% of the stock of DENTSPLY SIRONA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about DENTSPLY SIRONA's insider trading history.
Receive XRAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DENTSPLY SIRONA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XRAY Stock News Headlines

DENTSPLY SIRONA (XRAY) Receives a Sell from Citi
Batten down the hatches – Project Tengu is coming
Starting June 16, This AI Lab Could Take Off Dramatically Time magazine recently named this lab "the most disruptive company in the world." It's not SpaceX or OpenAI. In fact, its annualized revenues have already surpassed both of these firms. And this 60-year Wall Street legend believes it's gearing up for a watershed product launch that could send its sales soaring even higher starting June 16.tc pixel
Dentsply Sirona (XRAY) Q1 2026 Earnings Transcript
DENTSPLY SIRONA Inc. (XRAY) Q1 2026 Earnings Call Transcript
See More Headlines

XRAY Stock Analysis - Frequently Asked Questions

DENTSPLY SIRONA's stock was trading at $11.43 at the start of the year. Since then, XRAY stock has decreased by 3.8% and is now trading at $11.00.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) announced its earnings results on Tuesday, May, 5th. The medical instruments supplier reported $0.27 earnings per share for the quarter, missing analysts' consensus estimates of $0.28 by $0.01. DENTSPLY SIRONA's revenue for the quarter was up .1% compared to the same quarter last year.
Read the conference call transcript
.

DENTSPLY SIRONA subsidiaries include Propel Orthodontics LLC, Datum Dental Ltd., Straight Smile LLC, OraMetrix Inc, Recherche Techniques Dentaires, MIS Implants Technologies Ltd, Sirona Dental System, and others.

DENTSPLY SIRONA's top institutional investors include Dimensional Fund Advisors LP (1.78%), Bank of New York Mellon Corp (0.70%), Jennison Associates LLC (0.54%) and Great Hill Capital LLC (0.50%). Insiders that own company stock include Glenn Coleman, Gregory T Lucier and James D Forbes.
View institutional ownership trends
.

Shares of XRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that DENTSPLY SIRONA investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and ExxonMobil (XOM).

Company Calendar

Last Earnings
5/05/2026
Today
5/08/2026
AGM 2026
6/02/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED/DENTAL - SUPP
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:XRAY
CIK
818479
Employees
14,000
Year Founded
1899

Price Target and Rating

High Price Target
$17.00
Low Price Target
$10.00
Potential Upside/Downside
+25.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
14 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
7.75
P/E Growth
1.3
Net Income
-$598 million
Net Margins
-17.06%
Pretax Margin
-15.54%
Return on Equity
18.83%
Return on Assets
5.13%

Debt

Debt-to-Equity Ratio
1.52
Current Ratio
1.53
Quick Ratio
1.03

Sales & Book Value

Annual Sales
$3.68 billion
Price / Sales
0.60
Cash Flow
$6.01 per share
Price / Cash Flow
1.83
Book Value
$6.58 per share
Price / Book
1.67

Miscellaneous

Outstanding Shares
200,330,000
Free Float
199,325,000
Market Cap
$2.20 billion
Optionable
Optionable
Beta
0.93

Social Links

The 7 Hottest IPOs On Wall Street’s 2026 Watchlist Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NASDAQ:XRAY) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners